Condition | Median CD4 (IQR1) | Confirmed | Probable | Total (%) |
---|---|---|---|---|
Pneumocystis carinii pneumonia | 16.5 (9 – 40) | 203 | 139 | 342 (35.7) |
Mycobacterium tuberculosis | 52 (18 – 110) | 148 | 70 | 218 (22.7) |
Herpes simplex, chronic mucocutaneous | 25 (9 – 63) | 26 | 45 | 71 (7.4) |
Candidiasis, esophageal or tracheobronchial | 21 (8.5 – 86) | 25 | 41 | 66 (6.9) |
Cytomegalovirus disease | 25 (10 – 51) | 28 | 12 | 40 (4.2) |
Cryptococcosis, extrapulmonary | 13 (6.5 – 39) | 41 | NA | 41 (4.3) |
Cytomegalovirus retinitis | 15 (8 – 38.5) | 0 | 37 | 37 (3.9) |
Mycobacterium avium, disseminated | 13 (5 – 26) | 35 | NA | 35 (3.6) |
Toxoplasmosis of the brain | 29 (15 – 44) | 1 | 31 | 32 (3.3) |
Mycobacterium, species unidentified | 31 (12 – 80) | 0 | 16 | 16 (1.7) |
Kaposi's sarcoma | 46.5 (23.5 – 227.5) | 8 | 4 | 12 (1.3) |
Cryptosporidiosis, chronic intestinal | 31 (4 – 56) | 8 | NA | 8 (0.8) |
Burkitt's lymphoma | 34 (15.5 – 64) | 8 | NA | 8 (0.8) |
Wasting syndrome of HIV | 36 (25 – 65) | NA | 6 | 6 (0.6) |
Progressive multifocal leukoencephalopathy | 42.5 (24.5 – 56.5) | 2 | 3 | 5 (0.5) |
Histoplasmosis, disseminated | 22 (4 – 138) | 5 | NA | 5 (0.5) |
Other2 | ----- | 11 | 6 | 17 (1.8) |
Total | 27 (11 – 63) | 549 | 410 | 959 (100) |